SCHEMBL26041233

SCHEMBL26041233

N#Cc1cccc(-c2ccc(-c3nc(-c4ccccc4-c4cccc(C#N)c4)nc(-c4ccc(-c5cccc(C#N)c5)cc4-n4c5ccc(-c6ccccc6)cc5c5cc(-c6ccccc6)ccc54)n3)c(-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 1/20 0.41
CYP1A2 P05177 8/20 0.38
CYP3A4 P08684 7/20 0.38
CLK4 Q9HAZ1 6/20 0.38
ALDH1A1 P00352 5/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
LMNA P02545 4/20 0.38
TSHR P16473 4/20 0.38
CYP2D6 P10635 4/20 0.38
HSD17B10 Q99714 3/20 0.38
CYP2C19 P33261 2/20 0.38
MAPK1 P28482 2/20 0.38
CYP2C9 P11712 2/20 0.38
PDK2 Q15119 1/20 0.38
ADORA2A P29274 2/20 0.37
MAP4K4 O95819 1/20 0.37
TP53 P04637 3/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26051883 0.98 ALDH1A3 (0.39) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL26051219 0.97 ALDH1A3 (0.39) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL26055369 0.97 CYP1A2 (0.42) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL26041243 0.96 ALDH1A3 (0.39) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL26052285 0.95 ALDH1A3 (0.38) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL26055850 0.94 CYP1A2 (0.40) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL26055525 0.94 CYP1A2 (0.40) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL24924217 0.93 CYP1A2 (0.44) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL22916808 0.93 CYP1A2 (0.44) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL26040830 0.93 CYP1A2 (0.44) ALDH1A3CYP1A2CYP3A4CLK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-31 US disclosed
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES TYR, WIZ, NR2E3 ALDH1A3 301/4885CYP1A2 236/4885CYP3A4 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.